Stuart M Sprague
Overview
Explore the profile of Stuart M Sprague including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
110
Citations
1924
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ashfaq A, Choe J, Strugnell S, Patel N, Sprague S, Norris K, et al.
Am J Nephrol
. 2025 Feb;
:1-21.
PMID: 39987904
Introduction: Sustained 30% reductions of intact parathyroid hormone (iPTH) with ERC are associated with slower decline in estimated glomerular filtration rate (eGFR) in ND-CKD patients with SHPT. Such iPTH reductions...
2.
3.
Karaboyas A, Zhao J, Ma J, Moore C, Saleem N, Martin K, et al.
Clin J Am Soc Nephrol
. 2024 Oct;
PMID: 39378354
No abstract available.
4.
Bishop C, Ashfaq A, Strugnell S, Choe J, Patel N, Norris K, et al.
Am J Nephrol
. 2024 Aug;
:1-10.
PMID: 39191216
Introduction: Chronic kidney disease (CKD) drives onerous human and healthcare costs, underscoring an urgent need to avert disease progression. Secondary hyperparathyroidism (SHPT) develops as CKD advances, and persistently elevated parathyroid...
5.
Sprague S, Edelstein S, Spiegel D, Rosenbaum D, Thomas C, Weiner D
Curr Med Res Opin
. 2024 Jul;
40(8):1335-1343.
PMID: 39041739
No abstract available.
6.
Hill Gallant K, Sprague S, Rosenbaum D, Spiegel D, Kozuka K, Edelstein S, et al.
J Ren Nutr
. 2024 Jul;
35(1):25-34.
PMID: 38992521
Because of increased risks of cardiovascular disease and death, patients with hyperphosphatemia receiving maintenance dialysis are advised to limit phosphorus consumption and are prescribed phosphate binders in an effort to...
7.
Trujillo J, Alotaibi M, Seif N, Cai X, Larive B, Gassman J, et al.
Kidney360
. 2024 Apr;
5(5):681-689.
PMID: 38570905
No abstract available.
8.
Sprague S, Weiner D, Tietjen D, Pergola P, Fishbane S, Block G, et al.
Kidney360
. 2024 Feb;
5(5):732-742.
PMID: 38323855
No abstract available.
9.
Medaura J, Zhou M, Ficociello L, Anger M, Sprague S
Am J Nephrol
. 2023 Dec;
55(2):127-135.
PMID: 38091973
Introduction: Sucroferric oxyhydroxide (SO), a non-calcium, chewable, iron-based phosphate binder (PB), effectively lowers serum phosphorus (sP) concentrations while reducing pill burden relative to other PBs. To date, SO studies have...
10.
Kalantar-Zadeh K, Forfang D, Bakris G, Martin K, Moe S, Sprague S
Kidney360
. 2023 Oct;
4(11):1650-1656.
PMID: 37870525
Most patients receiving dialysis rely on dietary restriction and phosphate binders to minimize the risk of hyperphosphatemia, which is associated with increased mortality. However, dietary restriction is difficult because of...